Skip to main content

Table 2 Subgroup analysis of the prevalence (p) of HIV treatment failure based on overall HAART, immunological, virological, and clinical definition by region, age, and study design in Ethiopia

From: HIV/AIDS treatment failure and associated factors in Ethiopia: meta-analysis

Subgroup analysisOverall HAART failure P (95%CI)Immunological failure P (95%CI)Virological failure P (95%CI)Clinical failure P (95% CI)
By Region
 Amhara13.7 (7.3–20.2)9.3 (3.3–15.2)7.1 (0.03–14.1)5.7 (2.6–8.9)
 Oromia18.8 (16.8–20.8)8.9 (4.2–13.6)5.3 (3.8–6.8)8.8 (1.9–15.7)
 Addis Ababa18.4 (13.6–23.3)13.2 (7.9–18.4)1.5 (1.0–2.0)5.5 (4.4–6.6)
 Tigray__6.5 (4.9–8.2)11.5 (9.6–13.4)__
By age of participants
 All age group20.0 (18.4–21.6)11.2 (2.0–20.4)11.0 (9.9–12.2)11.2 (9.7–12.7)
 Adult16.0 (7.4–24.7)12.9 (7.6–18.3)2.8 (1.5–4.1)4.6 (2.9–6.3)
 Children14.6 (9.7–19.6)6.4 (3.6–9.3)__6.4 (4.2–8.5)
By Study design
 Cross-sectional14.1 (3.0–25.2)8.1 (2.7–13.5)8.5 (3.2–13.9)7.2 (0.8–15.8)
 Cohort16.8 (12.2–21.37)11.2 (6.8–15.6)2.6 (1.1–4.0)6.0 (4.5–7.5)
Combined15.8 (11.6–20.1)10.2 (6.9–13.6)5.6 (2.9–8.3)6.3 (4.6–8.0)
  1. __ denotes no estimation due to lack of original studies
\